Revenues of $5.3 million, Improved Gross Margin, and Positive Net Income MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, reports results for its second quarter and first half of fiscal 2025 ended March 31, 2025 (“ Q2 ” and “ H1 ”). Sales for Q2 and H1 reflected differential growth between Antigens... Read More

Pilot Program for Qualifying Clinical Labs to Diagnose Bacterial Vaginosis MISSISSAUGA, Ontario and HELSINKI, Finland, May 13, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, and Aurevia Oy via its Labquality EQAS affiliate ( Aurevia ), announce a pilot external quality assessment (“ EQA ”) program to help clinical laboratories... Read More

MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its second quarter of fiscal 2025 ended March 31, 2025 (“ Q2 2025 ”) prior to the start of trading on May 15, 2025. At 11:00 AM... Read More

MISSISSAUGA, Ontario, May 05, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc . ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that its funding and commercialization partner, Sequel Pharma, LLC (“ Sequel ”), has executed an agreement with a leading international contract development and manufacturing organization (“ CDMO ”) for production of the formulated and... Read More

MISSISSAUGA, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the 2025 Bloom Burton & Co. Healthcare Investor Conference (the “ Conference ”) taking place at the Metro Toronto Convention Centre, North Building, on Monday and Tuesday, May 5 & 6, 2025. The Conference... Read More

MISSISSAUGA, Ontario, April 09, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it will be attending and exhibiting at ESCMID Global 2025 and that a customer and collaborator will be presenting results of a pilot External Quality Assessment ( EQA ) program enabled by Microbix Quality Assessment Products ( QAPs™ ).... Read More

MISSISSAUGA, Ontario, April 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQB: MBXBF ) (“ Microbix® ” or the Company ”), a life sciences innovator, manufacturer, and exporter, provides an update on U.S. and reciprocal tariff outcomes as well as business conditions and its outlook for the balance of its fiscal 2025. As has been widely reported, on April 2 the United States government imposed tariffs on... Read More

MISSISSAUGA, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQB: MBXBF ) (“ Microbix® ” or the “ Company ”), a life sciences innovator and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “ Meeting ”) which was held on March 26, 2025. At the Meeting, 42.83% of the issued and outstanding shares were represented. Shareholders... Read More

MISSISSAUGA, Ontario, March 26, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces the further optimization of the structure and utilization of its capital via the repayment of mortgage debt and expansion of its bank line of credit – moves that reduce interest expenses while maintaining strategic flexibility and... Read More

MISSISSAUGA, Ontario and MELBOURNE, Australia, March 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, and the Australian Centre for the Prevention of Cervical Cancer ( ACPCC ) with its Australian HPV Reference Laboratory, announce that they have signed a Memorandum Of Understanding ( MOU ) under which Microbix will supply its... Read More

MISSISSAUGA, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a proudly Ontario Made life sciences innovator, manufacturer, and exporter, was pleased to host Government of Ontario candidates Premier Doug Ford (Etobicoke North riding) and local MPP Deepak Anand (Mississauga-Malton riding). During their site visit on the morning of February 27 — Ontario’s Provincial... Read More

MISSISSAUGA, Ontario, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces the issuance of stock options under its shareholder-approved stock option plan (the “Stock Option Plan”), as part of its compensation programs to incentivize and retain its board of directors, executives, and managers. Details of the Option... Read More

MISSISSAUGA, Ontario, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to equity investors at the Whistler Capital Event conference, organized by Capital Event Management Ltd. and being hosted at the Fairmont Chateau Whistler, in Whistler, British Columbia, February 21 to 23, 2025.... Read More

MISSISSAUGA, Ontario, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, reports results for its first quarter of fiscal 2025 ended December 31, 2024 (“ Q1 ”). Results for Q1 demonstrated the results of ongoing efforts to increase recurring sales of Microbix’s diagnostic-test related ingredients and devices businesses, work... Read More

MISSISSAUGA, Ontario, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its first quarter of fiscal 2025 ended December 31, 2024 (“ Q1 2025 ”) prior to the start of trading on February 13, 2025. At 11:00 AM ET on that day,... Read More

MISSISSAUGA, Ontario, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it has received C$ 2.4 million in new equity capital from the partial exercise of expiring share purchase warrants. The warrants were issued in connection with a private placement undertaken in January, 2020, and had an exercise price of... Read More

MISSISSAUGA, Ontario and TRAVERSE CITY, Mich., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, and American Proficiency Institute ( API ), a groundbreaking supplier of proficiency testing (“ PT ”) to over 20,000 clinical laboratories, announce the start of a pilot PT program to ensure that molecular diagnostic (“ MDx ”)... Read More

MISSISSAUGA, Ontario, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces its intentions to broaden its platform capabilities to enable production of a wider range of test ingredients (“ Antigens ”) by using recombinant production technologies. Directing existing in-house synthetic biology capabilities to this... Read More

MISSISSAUGA, Canada, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, reports results for its fiscal year and fourth quarter ended September 30, 2024 (“ 2024 ” and “ Q4 ”) with record revenues, reflective of ongoing progress to increase sales from its diagnostic-test related ingredients and devices businesses and that... Read More

MISSISSAUGA, Ontario, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its fourth quarter of fiscal 2024 ended September 30, 2024 (“ Q4 2024 ”) prior to the start of trading on December 19, 2024. At 11:00 AM ET on that... Read More

MISSISSAUGA, Ontario and MANCHESTER, United Kingdom, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, and EMQN CIC ( EMQN ), a global supplier of laboratory external quality assessment (“ EQA ”) schemes for human genomic testing, announce the go-live of a program to support the accurate identification of patients who carry... Read More

MISSISSAUGA, Ontario, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ) (“Microbix” or the “Company”), a life sciences innovator, manufacturer, and exporter, announces the initiation of a Normal Course Issuer Bid (“ NCIB ”) program for the repurchase and cancellation of outstanding common shares. Specifically, the NCIB enables Microbix to repurchase up to 6,726,560 Common Shares... Read More

MISSISSAUGA, Ontario, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that key opinion leader (“ KOL ”) collaborators are presenting results of a Microbix Quality Assessment Product (“ QAP™ ”) for controlling testing for high-risk types of Human Papilloma Virus (“ HPV ”) at the 36 th annual International... Read More

MISSISSAUGA, Ontario, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of a novel Quality Assessment Product (“ QAP™ ”) for supporting patient diagnosis and tissue analysis relating to infection with the Herpes Simplex Virus (“ HSV ”) at the European Meeting on Molecular Diagnostics... Read More

MISSISSAUGA, Ontario, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it has upgraded its European Union (“ EU ”) regulatory compliance for its diagnostic assay quality assessment products (“ QAPs™ ”). Specifically, Microbix has obtained recognition of its quality management system compliance with the EU In... Read More

MISSISSAUGA, Ontario, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Muskoka Capital Conference, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau Muskoka, in Minett, Ontario, September 27 to 29, 2024. Microbix’s CEO, Cameron... Read More

MISSISSAUGA, Ontario, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and first nine months of fiscal 2024 ended June 30, 2024 (“ Q3 ” and “ YTD ”) with strong revenues, reflective of ongoing progress to increase sales from its diagnostic-test related ingredients and devices... Read More

MISSISSAUGA, Ontario, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its third quarter of fiscal 2024 ended June 30, 2024 (“ Q3 2024 ”) prior to the start of trading on August 14, 2024. Furthermore, at 10:00 AM ET on... Read More

MISSISSAUGA, Canada, July 25, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of a novel Quality Assessment Product (“ QAP™ ”) for supporting Point-of-Care-Tests (“ POCTs ”) for infection with the Hepatitis C Virus (“ HCV ”) at the American Diagnostic and Laboratory Medicine (“ ADLM ”)... Read More

MISSISSAUGA, Ontario, June 17, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces its hosting of Associate Minister of Small Business of Ontario, the Honourable Nina Tangri, to celebrate the opening of two expansions to its medical devices manufacturing capacity at one of its three adjacent Mississauga sites. Expansion one... Read More

MISSISSAUGA, Ontario, June 04, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it has successfully adapted and extended the use of its bioreactor capabilities for production of another clinically and commercially-important test-ingredient (a native “Antigen”). This achievement will enhance production capacity for... Read More

MISSISSAUGA, Ontario, May 15, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, reports results for its second quarter and first half of fiscal 2024 ended March 31, 2024 (“ Q2 ” and “ H1 ”), with strong growth in sequential and year-over-year quarterly revenues, reflective of ongoing progress to increase sales from its... Read More

Results Release and Webinar Discussion on Morning of May 15, 2024 MISSISSAUGA, Ontario, May 08, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its second quarter of fiscal 2024 ended March 31, 2024 (“ Q2 2024 ”) prior to the... Read More

MISSISSAUGA, Ontario, April 25, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that Labquality Ltd., a collaborator and customer, is presenting results of its use of Microbix Quality Assessment Products (“ QAPs™ ”) for accreditation of clinical labs for conducting molecular (“ MDx ”) tests for antimicrobial-resistant... Read More

MISSISSAUGA, Ontario, April 11, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference (the “ Conference ”) taking place at the Metro Toronto Convention Center, North Building, on April 16 and 17, 2024. The Conference provides an... Read More

MISSISSAUGA, Ontario, April 01, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQB: MBXBF ) (“ Microbix® ” or the Company ”), a life sciences innovator and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “ Meeting ”) which was held on March 27, 2024. At the Meeting, 42.64% of the issued and outstanding shares were represented. Shareholders voted... Read More

MISSISSAUGA, Canada, March 14, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that its funding and commercialization partner, Sequel Pharma, LLC (“ Sequel ”), has executed, with support from Microbix, an agreement with a leading international contract development and manufacturing organization (“ CDMO ”) for production... Read More

MISSISSAUGA, Ontario, March 11, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of Quality Assessment Products (“ QAPs™ ”) for supporting the quality control (“ QC ”) of histology and PCR-based tests driven by tissue-samples of Head and Neck cancer caused by human papilloma virus (“ HPV ”).... Read More

MISSISSAUGA, Ontario, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer and exporter, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the “Stock Option Plan”), as part of its compensation programs to incentivize and retain its board of directors, executives, and managers. Details of the... Read More

MISSISSAUGA, Ontario, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, reports results for its first quarter of fiscal 2024 ended December 31, 2023 (“ Q1 ”), with record quarterly revenues and a record quarterly profit, reflective of ongoing progress to increase sales from its diagnostic-test related ingredients and... Read More

MISSISSAUGA, Ontario, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its first quarter of fiscal 2024 ended December 31, 2023 prior to the start of trading on February 14, 2024. Furthermore, at 10:00 AM ET on that day,... Read More

MISSISSAUGA, Ontario, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of a Quality Assessment Product (“ QAP™ ”) for supporting the clinical use and accuracy of molecular (“ MDx ”) tests for infection with Helicobacter pylori (“ H. pylori ”), the bacterial cause of stomach ulcers,... Read More

MISSISSAUGA, Ontario, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces it has sold and shipped over one million Canadian Dollars (“ C$ 1 Million ”) of its quality assessment products (“ QAPs™ ”) to a leading agency that provides clinical laboratory accreditation services. This is Microbix’s largest-ever... Read More

MISSISSAUGA, Ontario, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, reports results for its year and fourth quarter ended September 30, 2023 (“ 2023 ” & “ Q4 ”), with solid sales and a resumption of profitability in Q4, ongoing progress to increase revenues from its diagnostic-test related ingredients and devices, and... Read More

MISSISSAUGA, Ontario and IRVINE, Calif., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces a collaboration with Seegene USA, Inc. (“ Seegene USA ”), a leading developer of multiplex molecular assays and automated solutions for U.S. labs. Under the parties’ collaboration, Seegene USA will distribute and recommend... Read More

MISSISSAUGA, Ontario and BIRMINGHAM, Ala., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces a collaboration with BioGX, Inc. (“ BioGX ”), a global provider of easy molecular diagnostic solutions. The companies are collaborating to make Microbix’s Quality Assessment Products (“ QAPs™ ”) available to BioGX Xfree ™... Read More

MISSISSAUGA, Ontario, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces the initiation of a Normal Course Issuer Bid (“ NCIB ”) program for the repurchase and cancellation of outstanding common shares. Specifically, the NCIB enables Microbix to repurchase up to 6,827,518 Common Shares (" Shares "), that number... Read More

MISSISSAUGA, Ontario, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Florida Capital Event Conference, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Turnberry, in Aventura, Florida, November 17 to 19, 2023. Microbix’s CEO &... Read More

MISSISSAUGA, Ontario, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces the reconfirmation of its agreement (“ Agreement ”) with Sequel Pharma, LLC (“ Sequel ”) to return Kinlytic® urokinase (“ Kinlytic ”) to market, initially for dissolving blood clots that block venous catheters (“ Catheter Clearance ”) in the... Read More

MISSISSAUGA, Ontario and TRIESTE, Italy, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces a collaboration with Ulisse Biomed S.p.A. ( BIT: UBM, Ulisse ), a company developing innovative diagnostics, theranostics, and therapeutics. The companies are collaborating to make Microbix’s Quality Assessment Products (“... Read More

MISSISSAUGA, Ontario, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that its quality assessment products (“QAPs™”) are supporting a testing program for Human Papilloma Virus (“HPV”) using molecular diagnostic (“MDx”) technology at Dublin’s The Coombe Hospital, in the Republic of Ireland, an EU member-state.... Read More

MISSISSAUGA, Ontario, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Muskoka Capital Conference, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau Muskoka, in Minett, Ontario, September 29 to October 1, 2023. Microbix’s CEO,... Read More

MISSISSAUGA, Ontario, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it has secured record purchase orders (“ P.Os. ”) for over one million Canadian Dollars (“ C$ 1 Million ”) of its quality assessment products (“ QAPs™ ”) from a leading global maker of infectious disease diagnostic tests, QuidelOrtho... Read More

MISSISSAUGA, Ontario, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, honours the passing of its founder, William J. (Bill) Gastle, surrounded by family in Edmonton, Alberta on September 6, 2023. Bill trained as a virologist and founded Microbix in 1984. The Company began with the sale of bacterial and cellular growth... Read More

MISSISSAUGA, Ontario, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and YTD fiscal 2023 ended June 30, 2023 (“ Q3 ” and “ YTD ”), a period in which strong revenues were realized along with a fully-funded partnering of its drug asset Kinlytic ® urokinase (“ Kinlytic ”). Management... Read More

MISSISSAUGA, Ontario, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces its successful adoption of software to upgrade, digitize, and integrate its Enterprise Resource Planning (“ ERP ”) platform and electronic Quality Management System (“ eQMS ”). These logistics IT systems are intended to facilitate growth in... Read More

MISSISSAUGA, Ontario, July 24, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of its Quality Assessment Products (“ QAPs™ ”) for supporting the clinical use and accuracy of multiplex tests for four of the most prevalent sexually-transmitted infections (“ STIs ”) at the American Association... Read More

MISSISSAUGA, Ontario, July 05, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that its quality assessment products (“ QAPs™ ”) have been selected to support a screening program for Human Papilloma Virus (“ HPV ”) using molecular diagnostic (“ MDx ”) technology across The Netherlands, an EU member-state. Microbix’s... Read More

Innovative “EQA” Program to Qualify Labs for Genital Ulcer Disease Testing MISSISSAUGA, Canada and HELSINKI, Finland, June 20, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter and Labquality Oy ( Labquality ), a global provider of laboratory external quality assessment (“ EQA ”) programs, announce their creation of the world’s first... Read More

MISSISSAUGA, Ontario, June 13, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter announces that it is presenting results of its Quality Assessment Products (“ QAPs™ ”) for supporting the clinical use and accuracy of tests for antimicrobial-resistant (“ AMR ”) sexually-transmitted infections (“ STIs ”) at the ASM Microbe conference... Read More

MISSISSAUGA, Ontario, May 18, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQB: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces it has applied to the TSX to extend the term of an aggregate of 5,750,000 common share purchase warrants (“ Warrants ”) which were issued in connection with Microbix’s May 19, 2021 prospectus and private placement financings. The Warrants now... Read More

MISSISSAUGA, Ontario, May 16, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces execution of an agreement (“ Agreement ”) to return Kinlytic ® urokinase (“ Kinlytic ”) to market, initially for dissolving blood clots in venous catheters in the United States and to be followed by other geographies and clinical indications.... Read More

MISSISSAUGA, Ontario, May 11, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, reports results for its second quarter and first half of fiscal 2023 ended March 31, 2023 (“ Q2 ” and “ H1 ”), a period in which a loss was incurred in the first quarter and profitability restored in Q2. Microbix remains well-capitalized and is targeting... Read More

MISSISSAUGA, Ontario, April 20, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Center, North Building, on April 25 th and 26 th , 2023. The Conference provides an... Read More

MISSISSAUGA, Ontario, March 30, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF)( “Microbix ® ” or the “Company”), a life sciences innovator, manufacturer, and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “ Meeting ”) which was held on March 29, 2023. At the Meeting, 48.77% of the issued and outstanding shares were represented.... Read More

MISSISSAUGA, Ontario, March 20, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it is undertaking further expansions to its capabilities and capacity for manufacturing specialized products relating to diagnostic testing for infectious diseases. The Government of Ontario is supporting the expansions at Microbix’s... Read More

MISSISSAUGA, Ontario, March 01, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that its Quality Assessment Products (“ QAPs™ ”) are now supporting test accuracy within a program to provide Point-of-Care Testing (“ PoCT ”) for Sexually-Transmitted Infections (“ STIs ”) in remote communities across Australia. An initial... Read More

MISSISSAUGA, Ontario, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer and exporter, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the “Stock Option Plan”), as part of its compensation programs to incentivize and retain its board of directors, executives, and managers. Details of the... Read More

MISSISSAUGA, Ontario, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, reports results for its first quarter ended December 31, 2022 (“ Q1 ”), a period in which reduced sales across two major product lines resulted in the first quarterly net loss in two years. Microbix remains well-capitalized and is targeting to continue... Read More

MISSISSAUGA, Ontario, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting results of its collaboration with the Microbiology Laboratory of the Queen Elizabeth Hospital of Health PEI (“ Health PEI ”), in support of provincial adoption of molecular diagnostic (“ MDx ”) screening for Human... Read More

MISSISSAUGA, Ontario, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it is launching a new quality assessment product (“ QAP™ ”) to support molecular diagnostic (“ MDx ”) testing for the Non-Variola Orthopoxvirus (“ Mpox ”), the cause of the cutaneous infection colloquially-known as “Monkeypox.” From... Read More

MISSISSAUGA, Ontario, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, reports results for its year and fourth quarter ended September 30, 2022 (“ 2022 ” and “ Q4 ”), with record sales and continued positive net earnings, plus ongoing progress upon its strategic goal of increasing its capacity for medical devices... Read More